The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 will address basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, alcohol-associated liver disease and MetALD, and metabolic dysfunction-associated liver disease.